抗菌肽的研究进展

抗菌肽又称抗微生物肽(antimicrobial peptide)或肽抗生素(peptide antibiotics),在动植物体内分布广泛,是天然免疫防御系统的一部分。抗菌肽不仅有广谱抗细菌能力,而且对真菌、病毒及癌细胞也有作用。对抗菌肽作用机理的研究是近来的热点之一,本文综述了此方面近来的进展,并对微生物针对抗菌肽的耐药性进行了讨论。     

抗菌肽及其临床应用研究进展

抗菌肽是生物体在抵抗病原微生物的防御反应过程中产生的一类具有抗微生物活性的小分子多肽。抗菌肽是机体天然免疫系统的重要组成部分,具有广谱的抗革兰氏阳性、阴性菌活性,对真菌、某些有包膜的病毒、寄生虫以及肿瘤细胞也有抑制活性。抗菌肽具有不同于传统抗生素的独特抗菌机制,病原菌不宜对其产生耐药性,有可能成为一种新的抗生素替代品。介绍了抗菌肽的来源与分类、理化特性与生物学活性,并重点阐述其最新的临床应用进展。     

抗菌肽在转基因动植物中的研究进展

抗菌肽是一类广泛存在于生物界的小分子短肽,具有广谱的抗菌、抗病毒、抗寄生虫及抗癌等生物活性.将抗菌肽基因转入动、植物体内,不仅可以提高动、植物的抗病能力,而且有望通过转基因动、植物来大量生产抗菌肽,具有重要的研究价值和广阔的应用前景.就抗菌肤的特性、抗菌机理及其在转基因动、植物中的研究做一简要的综述.     

昆虫抗菌肽对病原微生物作用的研究进展

在诱导和非诱导情况下,昆虫能产生各种类型的具有体液免疫功能的小分子物质-抗菌肽,参与机体对入侵病原微生物的免疫应答反应,构成了机体独特的免疫系统和免疫机制。这类抗菌肽或抗菌蛋白也存在于其它动物。研究表明,抗菌肽对细菌、真菌、病毒和原虫都具有作用,甚至对癌细胞也具有杀伤作用。随着抗菌肽家族的不断扩大,其结构研究的深入,相继提出了一些崭新的杀菌方式和作用机制。本文从目前国内外这方面的研究入手,分析各抗菌肽的作用特点、杀菌作用模式,展望了基因工程及临床应用的前景。     

类弹性蛋白ELPs融合表达在抗菌肽分离纯化中的应用（简报）

抗菌肽（Antimicrobial polypeptides,AMPs）是两性带电分子,广泛存在于多种生物体内,具有广谱抗菌、调节免疫、抑制肿瘤等多种生物学功能。一些抗菌肽不仅对耐药性的病原细菌有很好的抑制和杀灭作用,而且还对真菌、原生动物、病毒等有很好的抑制作用。近年研究还发现,某些抗菌肽还可选择性杀伤肿瘤细胞,     

动物抗菌肽

动物抗菌肽是有抗菌作用的小分子蛋白质 ,是宿主先天性非特异性防御系统的重要组分。机体受到损伤或病原微生物入侵时 ,能迅速产生抗菌肽杀伤入侵者。Ｂｏｍａｎ称抗菌肽是机体理想的第一道防线 ,因为抗菌肽的合成速度非常快 ,与以恒定的肽键合成速度相比较 ,抗菌肽的产生比ＩｇＭ快 10 0多倍。而且 ,小肽的扩散比大蛋白质和免疫细胞更加迅速 ,作用更显灵活。自 2 0世纪 80年代早期 ,天蚕素和防御素分离纯化鉴定以来 ,天然抗菌肽的研究引起了人们的极大兴趣。迄今为止 ,大约 2 0 0 0多种抗菌肽被分离出来 ,在哺乳动物、两栖类、昆虫中均已发…     

抗菌肽SMAP-29结构功能及分子设计策略

抗菌肽是生物体内产生的一种具有生物活性的小分子多肽,具有广谱抗细菌、抗病毒、抗真菌甚至抗癌作用。SMAP-29是来源于绵羊骨髓细胞,包含29个氨基酸的Cathelicidin类α-螺旋结构抗菌肽。SMAP-29具有多种生物活性,包括抗革兰氏阳/阴性菌、抗真菌、抗病毒、抗寄生虫、抗螺旋体、抗衣原体和中和内毒素活性,并且具有作用机制独特、快速杀灭细菌的特点。以下综述了SMAP-29抗菌肽家族的基因和蛋白结构、结构与活性关系、作用机制、生物功能、基因重组表达,重点阐述了SMAP-29结构、分子设计的必要性和基于     

抗菌肽与肠道健康研究新进展

抗菌肽是生物体内诱导产生的一类具有抗菌作用的生物活性肽,在机体抵抗病原入侵方面起着重要作用。近年来,肠道微生态研究炙手可热,抗菌肽与肠道健康的研究正广泛开展。相关研究结果表明,抗菌肽表达水平的高低可以用来评估机体肠道健康状态,从而监测抗菌肽表达水平来建立一种疾病预防和治疗过程中的辅助诊断手段。本文围绕抗菌肽对肠道菌群结构和免疫影响两方面的最新研究进展进行归纳与分析,旨在为临床诊断与治疗提供参考。     

类弹性隆蛋白ELPs融合表达在抗菌肽分离纯化中的应用(简报)

抗菌肽(Antimierobial polypeDtides,AMPs)是两性带电分子,广泛存在于多种生物体内,具有广谱抗菌、调节免疫、抑制肿瘤等多种生物学功能.一些抗菌肽不仅对耐药性的病原细菌有很好的抑制和杀灭作用,而且还对真菌、原生动物、病毒等有很好的抑制作用.     

富含甘氨酸抗菌肽的研究进展

抗菌肽是机体先天免疫的重要组成部分,种类繁多。其中富含甘氨酸抗菌肽广泛存在于多种生物体,具有广谱抗菌活性,并且在药物治疗、农业、食品业等方面已经取得一定成绩,该文根据近年抗菌肽研究成果,综述了富含甘氨酸抗菌肽的分类、作用机制、存在的问题和应用前景。     

Single molecule resolution of the antimicrobial action of quantum dot-labeled sushi peptide on live bacteria

Background  

Antimicrobial peptides are found in all kingdoms of life. During the evolution of multicellular organisms, antimicrobial peptides were established as key elements of innate immunity. Most antimicrobial peptides are thought to work by disrupting the integrity of cell membranes, causing pathogen death. As antimicrobial peptides target the membrane structure, pathogens can only acquire resistance by a fundamental change in membrane composition. Hence, the evolution of pathogen resistance has been a slow process. Therefore antimicrobial peptides are valuable alternatives to classical antibiotics against which multiple drug-resistant bacteria have emerged. For potential therapeutic applications as antibiotics a thorough knowledge of their mechanism of action is essential. Despite the increasingly comprehensive understanding of the biochemical properties of these peptides, the actual mechanism by which antimicrobial peptides lyse microbes is controversial.     

水产动物抗菌肽的研究进展

抗菌肽广泛分布于多种生物,具有分子量小、耐热、广谱抗菌等特性。它在杀菌过程中不易产生耐药性,使其具有潜在的医药价值。本文综述了水产动物抗菌肽的结构特征、生物学活性、抗菌机制、目前克隆的基因的结构与功能,以及在免疫防御中的表达等一系列问题。     

抗菌肽的抗菌机制及其临床应用

抗菌肽是广泛存在于生物体内的一种小分子肽, 具有广谱性、高效性、稳定性等特点, 其本身不易产生耐药性。不仅具有杀菌作用, 还能抑杀真菌、寄生虫、病毒以及肿瘤细胞且对正常细胞毒性较小。新颖抗生素发现的缺乏, 导致了大量耐药菌株的出现, 抗菌肽有可能成为一种新的抗生素替代品。本文介绍了抗菌肽的结构特点、生物活性, 并重点阐述了其抗菌机制及最新临床应用进展。     

Staphylococcal resistance to antimicrobial peptides of mammalian and bacterial origin

Antimicrobial host defense peptides, such as defensins, protegrins, and platelet microbicidal proteins are deployed by mammalian skin, epithelia, phagocytes, and platelets in response to Staphylococcus aureus infection. In addition, staphylococcal products with similar structures and activities, called bacteriocins, inhibit competing microorganisms. Staphylococci have developed resistance mechanisms, which are either highly specific for certain host defense peptides or bacteriocins or which broadly protect against a range of cationic antimicrobial peptides. Experimental infection models can be used to study the molecular mechanisms of antimicrobial peptides, the peptide resistance strategies of S. aureus, and the therapeutic potential of peptides in staphylococcal diseases.     

抗菌肽抗肿瘤作用的研究进展

抗菌肽是生物体抵御外界病原体侵袭时产生的一类保守的小分子多肽,是生物体内先天免疫防御机制的重要组分。抗菌肽可以选择性杀伤肿瘤细胞,而对正常细胞损害较小,已作为化、放疗药物潜在的替代品被广泛研究和开发。从抗菌肽对不同肿瘤细胞选择性作用机制、抗菌肽药物设计的发展及应用前景等方面进行综述。     

Experimental and simulation studies reveal mechanism of action of human defensin derivatives

Antimicrobial peptides (AMPs) are naturally occurring promising candidates which can be used as antibiotics against a wide variety of bacteria. The key component for using them as a potent antibiotic is that their mechanism of action is less prone to bacterial resistance. However, the molecular details of their mechanism of action is not yet fully understood. In this study, we try to shed light on the mode of action of AMPs, possible reason behind it, and their interaction with lipid bilayers through experimental as well as molecular dynamics (MD) simulation studies. The focal of our study was Human beta defensin 3 (hBD-3) which is a naturally occurring AMP. We chose three derivatives of hBD-3, namely CHRG01, KSR, and KLR for the detailed analysis presented in this study. These three peptides are evaluated for their antibacterial potency, secondary structure analysis and mechanism of action. The experimental results reveal that these peptides are active against gram positive as well as gram negative bacteria and kill bacteria by forming membrane pores. The MD simulation results correlate well with the antibacterial activity and shed light into the early membrane insertion dynamics. Moreover, the specific amino acids responsible for membrane disruptions are also identified from the MD simulations. Understanding the molecular level interaction of individual amino acids with the lipid bilayer will greatly help in the design of more efficient antimicrobial peptides.     

Antimicrobial peptides: an overview of a promising class of therapeutics

Antibiotic resistance is increasing at a rate that far exceeds the pace of new development of drugs. Antimicrobial peptides, both synthetic and from natural sources, have raised interest as pathogens become resistant against conventional antibiotics. Indeed, one of the major strengths of this class of molecules is their ability to kill multidrug-resistant bacteria. Antimicrobial peptides are relatively small (6 to 100 aminoacids), amphipathic molecules of variable length, sequence and structure with activity against a wide range of microorganisms including bacteria, protozoa, yeast, fungi, viruses and even tumor cells. They usually act through relatively non-specific mechanisms resulting in membranolytic activity but they can also stimulate the innate immune response. Several peptides have already entered pre-clinical and clinical trials for the treatment of catheter site infections, cystic fibrosis, acne, wound healing and patients undergoing stem cell transplantation. We review the advantages of these molecules in clinical applications, their disadvantages including their low in vivo stability, high costs of production and the strategies for their discovery and optimization.     

Application of antimicrobial peptides in agriculture and food industry

Antimicrobial peptides have captured the attention of researchers in recent years because of their efficiency in fighting against pathogens. These peptides are found in nature and have been isolated from a wide range of organisms. Furthermore, analogs or synthetic derivatives have successfully been developed on the basis of natural peptide patterns. Long use of pesticides and antibiotics has led to development of resistance among pathogens and other pests as well as increase of environmental and health risks. Antimicrobial peptides are under consideration as new substitutes for conventional pesticides and antibiotics. Many plants and animals have been manipulated with antimicrobial peptide-encoding genes and several pesticides and drugs have been produced based on these peptides. Such strategies and products may still have a long way to go before being confirmed by regulatory bodies and others need to surmount technical problems before being accepted as applicable ones. In spite of these facts, several cases of successful use of antimicrobial peptides in agriculture and food industry indicate a promising future for extensive application of these peptides. In this review, we consider the developing field of antimicrobial peptide applications in various agricultural activities.     

Control of cell selectivity of antimicrobial peptides

Antimicrobial peptides (AMPs) are promising novel antibiotics, because they exhibit broad antimicrobial spectra and do not easily induce resistance. For clinical applications, it is important to develop potent AMPs with less toxicity against host cells. This review article summarizes the molecular basis for the cell selectivity (bacteria versus host cells) of AMPs and various attempts to control it, including the optimization of physicochemical parameters of peptides, the introduction of d-, fluorinated, and unusual amino acids into peptides, the constraining of peptide conformations, and the modification of peptides by polymers. Pros and cons of these approaches are discussed.